LGD-4665

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LGD-4665, covering 2024-12-16 to 2024-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation [Phase 2]

See pricing